That cognition headline got my skeptic side going

2026-10-07 3288 views 5 posts

I lift four mornings a week, keep protein around 160g, and guard sleep like it’s a meeting I can’t skip.

So when I saw the headline about GLP-1s and a lower predicted dementia risk, part of me wanted to file it under “too good, wait for better data.” Predicted risk is not a diagnosis, and the people on these meds probably already differ from the people off them in ways a study can’t fully untangle. I’m not dismissing it.

I just don’t want one more shiny headline to turn into a shortcut story. For me the useful angle is boring: better metabolic health, less inflammation, better sleep, consistent lifting, decent body composition.

I’m six months in, down 23 lbs, waist down 3 inches, and still more interested in the recomp trend than the hype cycle. Anyone else reading these brain-health stories with one eyebrow up?

Love that you’re guarding sleep like a meeting—that’s a huge win. Dumb question: do you track any cognition/focus data alongside your lifting?

I started a 1–10 focus score in my notes app right after my morning routine, plus sleep hours and whether I walked. After six weeks, my best days are almost always the boring combo: 7+ hours, lifting or a walk, and protein at breakfast—no single magic lever.

Deload weeks are weirdly my sharpest, which makes me think recovery matters as much as the workout. What does your non-negotiable wind-down look like?

I work nights, so I don’t trust my brain on vibes. I run a 2-minute reaction-time test after shifts and log it. My worst scores track with

Hi, total newbie here and also week one, so I’m mostly lurking and taking notes. The sleep-apnea angle is what nags me about those headlines: a lot of people starting this class of meds probably have undiagnosed or treated apnea, and that alone can scramble cognition.

I track sleep with a rig and my focus with a dumb 1–10 note in my phone, and the correlation for me is embarrassingly strong. Do you know if the bigger analyses adjust for apnea, or is that still a big open question?

Also, does “predicted risk” even move the needle for you personally, or is it more of a neat-if-true thing?

Right there with your skeptic side. My own spreadsheet has 14 months of dumb cognitive proxies—3-min typing accuracy, Wordle average, and how long it takes me to find my keys—and the trendlines track way more with training load and calendar chaos than anything else.

So my sharp Q for that headline: did they adjust for baseline BMI trajectory or just BMI at index? Weight-loss slope feels like the confounder I’d want peeled out before moving this from “wait for better data” to “interesting.” Also curious whether the predicted-risk model held up in an active-comparator cohort, not just pharmacy refills.